Athersys to Participate in Three Upcoming Conferences : comp

Athersys, Inc. , a regenerative medicine company developing MultiStem® cell therapy for critical care indications, announced today its participation in three upcoming conferences during the... | May 8, 2023

Related Keywords

Boston , Massachusetts , United States , Washington , Texas , American , Chris Temple , Sarah Busch , Head Of Business Development , Athersys Inc , Linkedin , Twitter , American Thoracic Society , Facebook , Nasdaq , Vice President , Pharma Manufacturing World Summit , Allogeneic Cell Therapies Summit , Regenerative Medicine , Business Development , Respiratory Innovation Summit , Gene Therapy , Annual Allogeneic Cell Therapies , Private Securities Litigation Reform Act , Texas Health Science Center , Annual Report , Athersys , Nc Stock Exchange , News , Information , Press Release , Regenerative , Medicine , Company , Developing , Fell , Therapy , Or , Critical , Mare , Nnounced , Oday , Its , Participation , N , Three , Pcoming , Conferences , Uring Athx Us04744l2051 ,